C
CBL International Ltd
NASDAQ:BANL
CBL International Ltd
NASDAQ:BANL
Price:
0.438
USD
-2.65%
Market Closed
Market Cap:
$12m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CBL International Ltd
NASDAQ:BANL
|
HK |
|
Kaisa Prosperity Holdings Ltd
HKEX:2168
|
CN |
|
B
|
Bal Pharma Ltd
NSE:BALPHARMA
|
IN |
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
NO |
|
S
|
Shh Resources Holdings Bhd
KLSE:SHH
|
MY |
|
SG Mart Ltd
BSE:512329
|
IN |
|
Sieyuan Electric Co Ltd
SZSE:002028
|
CN |
|
Shenzhen Tongyi Industry Co Ltd
SZSE:300538
|
CN |
|
Bilici Yatirim Sanayi ve Ticaret AS
IST:BLCYT.E
|
TR |
|
F
|
Flying Technology Co Ltd
SSE:603488
|
CN |
Balance Sheet
Balance Sheet Decomposition
CBL International Ltd
CBL International Ltd
Balance Sheet Decomposition is not available for
CBL International Ltd
CBL International Ltd
Balance Sheet
CBL International Ltd
CBL International Ltd
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
6
|
3
|
5
|
7
|
8
|
|
| Cash |
6
|
3
|
5
|
7
|
8
|
|
| Total Receivables |
18
|
20
|
18
|
25
|
37
|
|
| Accounts Receivables |
17
|
18
|
18
|
25
|
37
|
|
| Other Receivables |
1
|
2
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
4
|
0
|
19
|
23
|
|
| Total Current Assets |
23
|
27
|
24
|
52
|
68
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
|
| Total Assets |
24
N/A
|
27
+15%
|
26
-5%
|
53
+109%
|
69
+30%
|
|
| Liabilities | ||||||
| Accounts Payable |
18
|
18
|
13
|
27
|
42
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
19
|
19
|
13
|
28
|
46
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
19
N/A
|
19
-1%
|
13
-27%
|
28
+109%
|
46
+65%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
8
|
12
|
13
|
9
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
13
|
14
|
|
| Total Equity |
5
N/A
|
8
+73%
|
12
+44%
|
25
+109%
|
23
-9%
|
|
| Total Liabilities & Equity |
24
N/A
|
27
+15%
|
26
-5%
|
53
+109%
|
69
+30%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
25
|
25
|
21
|
25
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
